Internationally renowned ophthalmic surgeon Sheraz M. Daya, Founder and Medical Director of Centre for Sight has been awarded the 2026 Life Achievement Honor Award by the American Academy of Ophthalmology (AAO).
The accolade honors ophthalmologists who have demonstrated sustained commitment to the profession through education, leadership, committee service and participation in the Academy.
Founded by Mr. Daya in 1996, Centre for Sight has become internationally recognized for its work in advanced cataract surgery, laser vision correction, corneal transplantation and complex ophthalmic treatment.
A pioneer in refractive surgery, Mr. Daya introduced LASIK laser eye surgery to the UK in 1994, helping to establish new standards in vision correction. He has performed more than 30,000 cataract procedures and has been instrumental in developing and introducing surgical techniques and instruments now used by ophthalmologists internationally.
His career has combined clinical practice with research, innovation and education. After training and practising in the United States, he returned to the UK to lead the Corneoplastic Unit and Eye Bank at Queen Victoria Hospital in East Grinstead, where he helped develop an international reputation for corneal surgery. His pioneering work in corneal and stem cell treatments includes helping to restore the sight of acid attack survivor Katie Piper.
Mr. Daya commented: “Ophthalmology has changed beyond recognition during my career, but the purpose of our work remains the same: to improve the quality of people’s lives through better vision.
“I have been fortunate to work alongside extraordinary colleagues, researchers and surgeons across the world. Innovation is never the achievement of one person alone, and I see this award as recognition of the shared commitment to advancing treatment, challenging established thinking and achieving the best possible outcomes for patients.”
“As Centre for Sight marks its 30th anniversary, this award is a wonderful opportunity to reflect on how far eye care has progressed. But it is also a reminder of how much more we can achieve through research, collaboration and a relentless focus on patients.”